Solid cancers after bone marrow transplantation
- PMID: 9070469
- DOI: 10.1056/NEJM199703273361301
Solid cancers after bone marrow transplantation
Abstract
Background: The late effects of bone marrow transplantation, including cancer, need to be determined in a large population at risk.
Methods: We studied 19,229 patients who received allogeneic transplants (97.2 percent) or syngeneic transplants (2.8 percent) between 1964 and 1992 at 235 centers to evaluate the risk of the development of a new solid cancer. Risk factors relating to the patient, the transplant, and the course after transplantation were evaluated.
Results: The transplant recipients were at significantly higher risk of new solid cancers than the general population (observed cases, 80; ratio of observed to expected cases, 2.7; P<0.001). The risk was 8.3 times higher than expected among those who survived 10 or more years after transplantation. The cumulative incidence rate was 2.2 percent (95 percent confidence interval, 1.5 to 3.0 percent) at 10 years and 6.7 percent (95 percent confidence interval, 3.7 to 9.6 percent) at 15 years. The risk was significantly elevated (P<0.05) for malignant melanoma (ratio of observed to expected cases, 5.0) and cancers of the buccal cavity (11.1), liver (7.5), brain or other parts of the central nervous system (7.6), thyroid (6.6), bone (13.4), and connective tissue (8.0). The risk was higher for recipients who were younger at the time of transplantation than for those who were older (P for trend <0.001). In multivariate analyses, higher doses of total-body irradiation were associated with a higher risk of solid cancers. Chronic graft-versus-host disease and male sex were strongly linked with an excess risk of squamous-cell cancers of the buccal cavity and skin.
Conclusions: Patients undergoing bone marrow transplantation have an increased risk of new solid cancers later in life. The trend toward an increased risk over time after transplantation and the greater risk among younger patients indicate the need for life-long surveillance.
Comment in
-
Neoplasms and transplantation - trading swords for plowshares.N Engl J Med. 1997 Mar 27;336(13):949-50. doi: 10.1056/NEJM199703273361309. N Engl J Med. 1997. PMID: 9070477 No abstract available.
-
Solid cancers after bone marrow transplantation.N Engl J Med. 1997 Jul 31;337(5):345-6. N Engl J Med. 1997. PMID: 9235499 No abstract available.
Similar articles
-
New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia.J Clin Oncol. 2000 Jan;18(2):348-57. doi: 10.1200/JCO.2000.18.2.348. J Clin Oncol. 2000. PMID: 10637249
-
Secondary malignancies after bone marrow transplantation in adults.J Clin Oncol. 1994 Oct;12(10):2187-92. doi: 10.1200/JCO.1994.12.10.2187. J Clin Oncol. 1994. PMID: 7931488
-
Malignant neoplasms in long-term survivors of bone marrow transplantation. Late Effects Working Party of the European Cooperative Group for Blood and Marrow Transplantation and the European Late Effect Project Group.Ann Intern Med. 1999 Nov 16;131(10):738-44. doi: 10.7326/0003-4819-131-10-199911160-00004. Ann Intern Med. 1999. PMID: 10577296
-
Risk of secondary solid malignancies after allogeneic hematopoietic stem cell transplantation and preventive strategies.Future Oncol. 2015;11(23):3175-85. doi: 10.2217/fon.15.252. Epub 2015 Nov 9. Future Oncol. 2015. PMID: 26551415 Review.
-
Late effects after allogeneic bone marrow transplantation.Bone Marrow Transplant. 1994;14 Suppl 4:S11-3. Bone Marrow Transplant. 1994. PMID: 7728118 Review. No abstract available.
Cited by
-
Secondary solid cancer screening following hematopoietic cell transplantation.Bone Marrow Transplant. 2015 Aug;50(8):1013-23. doi: 10.1038/bmt.2015.63. Epub 2015 Mar 30. Bone Marrow Transplant. 2015. PMID: 25822223 Free PMC article. Review.
-
Three resected cases of esophageal carcinoma considered as being secondary solid tumors after bone marrow transplantation.Surg Case Rep. 2021 Mar 20;7(1):73. doi: 10.1186/s40792-021-01157-z. Surg Case Rep. 2021. PMID: 33744998 Free PMC article.
-
Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantation.Blood. 2012 Dec 6;120(24):4882-91. doi: 10.1182/blood-2012-06-437236. Epub 2012 Sep 25. Blood. 2012. PMID: 23012326 Free PMC article. Clinical Trial.
-
Contribution of HIV infection to mortality among cancer patients in Uganda.AIDS. 2013 Nov 28;27(18):2933-42. doi: 10.1097/01.aids.0000433236.55937.cb. AIDS. 2013. PMID: 23921614 Free PMC article.
-
Enhancing T cell reconstitution after hematopoietic stem cell transplantation: a brief update of the latest trends.Blood Cells Mol Dis. 2008 Jan-Feb;40(1):44-7. doi: 10.1016/j.bcmd.2007.07.015. Epub 2007 Oct 1. Blood Cells Mol Dis. 2008. PMID: 17905611 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical